ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1953

Machine Learning-Based Classification of Raynaud’s Phenomenon and Autoimmune Diseases in Indeterminate Capillaroscopic Patterns

Genessis Maldonado1, Adela Marin Ballve2, Luis Sáez Comet3, Mayka Freire Dapena4, Miguel Antonio Mesa5, Miguel Martín Cascón6, Gema María Lledó Ibáñez7, Elena Martínez Robles8, Begoña Marí-Alfonso9, Alfredo Guillén del Castillo10, Carmen Pilar Simeón Aznar10, Borja del Carmelo Gracia Tello2, Eduardo Ramos ibáñez11 and Tracy Frech12, 1Vanderbilt University Medical Center, Nashville, 2Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain, 3Hospital Universitario Miguel Servet; Zaragoza, Zaragoza, Spain, 4Hospital Clínico Universitario de Santiago de Compostela, La Coruña, Spain, 5Universidad Pontificia Bolivariana, Medellin, Colombia, 6Hospital General Universitario Morales Meseguer, Murcia, Spain, 7Hospital Clínic de Barcelona, Barcelona, Spain, 8Hospital Universitario La Paz, Madrid, Spain, 9Hospital Universitario Parc Taulí, Barcelona, Spain, 10Hospital Universitario Vall D´Hebron, Barcelona, Spain, 11Capillary.io, Zaragoza, Aragon, Spain, 12Vanderbilt University Medical Center, Nashville, TN

Meeting: ACR Convergence 2025

Keywords: Imaging, informatics, risk assessment

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 28, 2025

Title: (1936–1971) Imaging of Rheumatic Diseases Poster

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: Artificial intelligence (AI) has increasingly been integrated into the analysis of nailfold capillaroscopy (NFC), offering new opportunities to automate image interpretation and enhance diagnostic accuracy in rheumatologic conditions. NFC is a key non-invasive tool for the evaluation of Raynaud’s phenomenon (RP), which may be primary (PRP) or secondary to a connective tissue disease (CTD). Differentiating PRP from early or overlapping autoimmune conditions remains a clinical challenge, especially when NFC findings fall within a non-specific pattern -characterized by tortuosity, abnormal shapes, dilated capillaries, and microhemorrhages. The ability to detect subtle morphological differences using machine learning may support early diagnosis, risk stratification, and clinical decision-making. The aim of this study was to differentiate PRP from various autoimmune conditions that may present with secondary Raynaud’s or overlapping CTD features.

Methods: We developed a machine learning classifier using quantitative image-based features extracted via the Capillary.io platform1-2, Images were uploaded by multiple rheumatology centers across Europe. A 50-fold stratified cross-validation approach was employed to ensure robust performance estimation, with 20% of the cases (n=153) serving as the validation set in each fold.

Results: A total of 761 NFC cases were analyzed. All cases were automatically classified as having a non-specific capillaroscopic pattern by the Capi-Detect algorith. Clinical diagnoses were made independently, based on established criteria and without reference to the capillaroscopic findings. Among the cohort, 473 patients were diagnosed with PRP, while others were diagnosed with: inflammatory myopathies (n=49; including dermatomyositis n=38, polymyositis n=4, antisynthetase syndrome n=4, necrotizing myopathy n=2, overlap syndrome n=1), systemic lupus erythematosus (SLE; n=61), limited systemic sclerosis (lSSc; n=54), Sjögren’s syndrome (n=34), diffuse systemic sclerosis (dSSc; n=26), very early diagnosis of systemic sclerosis (VEDOSS; n=23), antiphospholipid syndrome (APS; n=9), and ANCA-associated vasculitis (n=3).The classifier achieved a mean weighted precision of 0.637, recall of 0.630, and F1-score of 0.632 across all folds. Weighted F1-scores ranged from 0.56 to 0.71, indicating performance variability across different data splits. The majority of misclassifications involved autoimmune cases being labeled as PRP (Figure 1), underscoring the morphological overlap that exists within the non-specific capillaroscopic pattern category.

Conclusion: These findings suggest that subtle but quantifiable differences exist between PRP and autoimmune diseases presenting with non-specific capillaroscopic patterns. Machine learning models may aid in identifying these distinctions and improving diagnostic interpretation. Further studies involving larger, more balanced cohorts are warranted to enhance model sensitivity, generalizability, and overall diagnostic performance.References: 1. Gema M Lledó-Ibáñez et al. Rheumatology, 2025; keaf073.2. Gracia Tello BC et al. Rheumatology (Oxford). 2024; keae197.

Supporting image 1Figure 1: Precision and Recall Across Folds


Disclosures: G. Maldonado: None; A. Marin Ballve: None; L. Sáez Comet: None; M. Freire Dapena: None; M. Mesa: None; M. Martín Cascón: None; G. Lledó Ibáñez: None; E. Martínez Robles: None; B. Marí-Alfonso: None; A. Guillén del Castillo: None; C. Simeón Aznar: None; B. Gracia Tello: None; E. Ramos ibáñez: None; T. Frech: None.

To cite this abstract in AMA style:

Maldonado G, Marin Ballve A, Sáez Comet L, Freire Dapena M, Mesa M, Martín Cascón M, Lledó Ibáñez G, Martínez Robles E, Marí-Alfonso B, Guillén del Castillo A, Simeón Aznar C, Gracia Tello B, Ramos ibáñez E, Frech T. Machine Learning-Based Classification of Raynaud’s Phenomenon and Autoimmune Diseases in Indeterminate Capillaroscopic Patterns [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/machine-learning-based-classification-of-raynauds-phenomenon-and-autoimmune-diseases-in-indeterminate-capillaroscopic-patterns/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/machine-learning-based-classification-of-raynauds-phenomenon-and-autoimmune-diseases-in-indeterminate-capillaroscopic-patterns/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology